Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.
Sign Up to like & getrecommendations! Published in 2017 at "Thrombosis research"
DOI: 10.1016/j.thromres.2017.09.001
Abstract: Dabigatran etexilate, rivaroxaban and apixaban (DOACs) are widely used and measurement of their concentration is desirable in certain clinical situations. Target-specific assays are available but limited information exists on their performance especially in their ability… read more here.
Keywords: multicenter; dabigatran rivaroxaban; target specific; rivaroxaban apixaban ... See more keywords